Lead global Phase 2b clinical studies in inflammation, oversee project execution, manage timelines and budgets, and mentor project teams.

The Central Risk Manager is responsible for developing and implementing strategies for Risk-Based Quality Management and Monitoring across clinical trials, collaborating with stakeholders, and leveraging data analytics for risk identification and mitigation.